Target intelligence / Profile preview

G-protein-activated inwardly rectifying potassium channel 1 (GIRK1 (also known as Kir3.1))

Target
GIRK1 (also known as Kir3.1)
Molecular classification
Ion channel, Inwardly rectifying potassium channel, G protein-gated ion channel
01

Overview

G-protein-activated inwardly rectifying potassium channel 1 (GIRK1, encoded by KCNJ3) is a subunit of the GIRK family of potassium channels that allows potassium ions to flow into, but less efficiently out of, excitable cells such as neurons and cardiac myocytes[1][3][5]. These tetrameric channels typically consist of GIRK1 in combination with other GIRK subunits (e.g., GIRK2, GIRK4), and are activated by the direct interaction of G protein βγ subunits, which are released upon activation of various GPCRs[1][3][5]. GIRK1-containing channels are key effectors in slowing heart rate in response to parasympathetic stimulation and in mediating inhibition in the central nervous system[2][4]. Activation hyperpolarizes the cell membrane, reduces excitability, and serves as a fundamental mechanism for physiological inhibition and rhythm modulation[1][3]. Dysregulation of GIRK1-associated channels contributes to several diseases, including cardiac arrhythmias and certain neuropsychiatric disorders, and selective activators and inhibitors are under investigation as therapeutic agents[3][5].

Other names
Kir3.1KCNJ3Girk1G protein-gated inward rectifier potassium channel 1G protein-coupled inwardly rectifying potassium channel 1
02

Mechanism of action

Drugs and neurotransmitters activate GIRK1-containing channels via G protein βγ subunits following GPCR activation, causing cell hyperpolarization - Direct binding and activation (for experimental small molecules such as ML297)

03

Biological functions

Regulation of cellular excitabilitySignal transductionMediation of inhibitory neurotransmitter effectsCardiac rate control
04

Disease associations

Cardiovascular disease (notably arrhythmias, atrial fibrillation)Neuropsychiatric and related disorders (implicated in epilepsy, addiction, mood disorders)Other (recent links to cancer cell growth and proliferation reported)
05

Safety considerations

Excessive activation can produce cardiac arrhythmias, including bradycardia and atrioventricular blockPotential for neuronal hyperpolarization leading to CNS depression, sedation, or seizure susceptibilityInteractions with multiple GPCR pathways raise polypharmacy and side effect concerns
06

Interacting drugs

ML297 (selective activator)

3 more in the full profile.

07

Biomarkers

Expression levels of KCNJ3 (GIRK1) in cardiac or neuronal tissue may serve as a biomarker in research or disease monitoring, but currently not standard in routine clinical practice

Beyond the preview

Go deeper on G-protein-activated inwardly rectifying potassium channel 1 (GIRK1 (also known as Kir3.1)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on G-protein-activated inwardly rectifying potassium channel 1 (GIRK1 (also known as Kir3.1)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call